Insulin resistance in the severely obese and links with metabolic co-morbidities

被引:24
作者
Stubbs, RS [1 ]
Wickremesekera, SK [1 ]
机构
[1] Wakefield Hosp, Wakefield Gastroenterol Ctr, Wellington, New Zealand
关键词
morbid obesity; co-morbidities; insulin resistance; gastric bypass; bariatric surgery;
D O I
10.1381/096089202321088110
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The association between insulin resistance (IR) and obesity and its causal relationship with type 2 diabetes is well recognized. The possibility of an association, causal or otherwise, with other obesity-related co-morbidities warrants consideration. Methods: IR was calculated pre-operatively in 80 patients undergoing gastric bypass surgery for severe obesity, using the homeostasis model assessment (HOMA) method, and again in 70 patients on at least one occasion post-operatively within 12 months. Correlations with weight parameters and pre-existing co-morbidities including diabetes, hypertension, dyslipidemia and hepatic steatosis were made. Results: 78/80 patients had IR pre-operatively which did not correlate with pre-operative weight or BMI. As expected, there were positive correlations between pre-operative IR and abnormal glucose tolerance and diabetes. A positive correlation was also found between IR and hepatic steatosis, but no correlation was noted between IR and hypertension or fasting levels of cholesterol, triglycerides or Choi/HDL cholesterol ratios. Improvement in IR was uniformly seen after gastric bypass, sooner than would be accounted for by weight loss alone. The degree of pre-operative IR was not a predictor of weight loss after gastric bypass in these patients. Conclusions: While IR is an almost universal accompaniment of severe obesity, it does not correlate with the degree of obesity in this group of patients. A number of important co-morbidities show a clear association with IR, and improvement in these after gastric bypass may well be related to striking and rapid changes in IR.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 36 条
[31]  
SCHEEN AJ, 1998, INT DIAB MONITOR, V10, P1
[32]  
Stubbs RS, 2001, NEW ZEAL MED J, V114, P239
[33]  
STUBBS RS, 2000, OBES PRAC, V2, P7
[34]   Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease [J].
Yip, J ;
Facchini, FS ;
Reaven, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2773-2776
[35]   CHANGES IN INSULIN AND LIPID-METABOLISM IN MALES WITH ASYMPTOMATIC HYPERURICEMIA [J].
ZAVARONI, I ;
MAZZA, S ;
FANTUZZI, M ;
DALLAGLIO, E ;
BONORA, E ;
DELSIGNORE, R ;
PASSERI, M ;
REAVEN, GM .
JOURNAL OF INTERNAL MEDICINE, 1993, 234 (01) :25-30
[36]   RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN HEALTHY-PERSONS WITH HYPERINSULINEMIA AND NORMAL GLUCOSE-TOLERANCE [J].
ZAVARONI, I ;
BONORA, E ;
PAGLIARA, M ;
DALLAGLIO, E ;
LUCHETTI, L ;
BUONANNO, G ;
BONATI, PA ;
BERGONZANI, M ;
GNUDI, L ;
PASSERI, M ;
REAVEN, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (11) :702-706